Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea
NCT06776432Phase 2Active, not recruiting
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Apr 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sivopixant, SASS-001 in sleep apnea, sponsored by Shionogi & Co., Ltd.. Started Apr 2025; status: active, not recruiting.
02
Drugs
sivopixantSASS-001
03
Conditions
sleep apnea
Beyond the preview
Go deeper on NCT06776432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06776432.